Healthtech Startups
15,468 companies tagged Healthtech, with their investors and founders.
Cala Health develops non-invasive prescription therapies for movement disorders, starting with a treatment for hand tremor and essential tremor. The company serves patients with chronic neurological and related conditions using bioelectronic medicine technology.
6 investors
Camber provides revenue cycle management infrastructure for specialty care practices, leveraging claims data and automation to reduce billing denials and accelerate reimbursement. The platform serves ABA therapy, physical therapy, and ENT/allergy clinics across the United States.
6 investors
Cambrian Bio is a clinical-stage drug development company creating precision therapeutics that target metabolic pathways which decline with age, such as AMPK and mTOR. Its lead asset, ATX-304, is an AMPK Network Activator being developed for obesity and prediabetes.
6 investors
Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment. The company partners with licensed dentists and orthodontists to provide high-quality orthodontic care.
6 investors
Capsule is an online pharmacy that coordinates with doctors and prior pharmacies to fill prescriptions and provides free same-day delivery, with customers paying only their usual insurance copay. It accepts commercial insurance, Managed Medicaid, and Medicare Part D, and texts users when refills are due.
6 investors
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management. Its FDA De Novo-cleared platform supports pressure-guided heart failure management for clinicians across hospital and home care settings.
6 investors
Cariloop provides digital and human-centered support services to relieve stress and anxiety experienced by family caregivers. The platform serves individuals managing the care of aging parents, children, and other loved ones.
6 investors
CG Oncology is a clinical-stage biotechnology company developing bladder-sparing oncolytic immunotherapies for patients with bladder cancer. Its lead investigational drug, cretostimogene, is an intravesically delivered immunotherapy being evaluated for non-muscle invasive bladder cancer (NMIBC).
6 investors
Chapter is a Medicare advisory service that compares plans from insurance carriers to help enrollees select coverage, and provides ongoing support including a free over-the-counter benefits app with home delivery. It serves individuals navigating Medicare in the United States.
6 investors
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
6 investors
Pharmaceutical company developing medicines and vaccines for patient health and treatment. Operating for over 130 years with focus on clinical research and drug development.
6 investors
Circle Medical provides telehealth services specializing in ADHD diagnosis and treatment for adults through remote video consultations with healthcare providers. The service offers affordable, convenient access to care for patients seeking ADHD assessment and medication management.
6 investors
CirrusMD offers a virtual primary care platform where patients connect with a physician via chat in under 60 seconds for diagnosis, treatment, and guidance to benefits and next steps in care. It sells to self-insured employers, health plans, and benefits consultants in the U.S., using chat-enabled smart technology to surface health concerns and manage chronic and behavioral conditions.
6 investors
Clarity Pediatrics provides evidence-based telehealth care for pediatric ADHD and anxiety, partnering with insurance providers to make care accessible to families. The practice serves children and families across California and Texas through clinician-led treatment aligned with American Academy of Pediatrics guidelines.
6 investors
Clinikally develops and sells dermatology-backed skin and hair care products for Indian consumers, complemented by online consultations with dermatologists. The company formulates medical-grade products targeting specific skin and hair conditions using high-quality ingredients sourced from Europe and the USA, with efficacy validated through clinical studies.
6 investors
Collectly provides AI-powered automation for healthcare revenue cycle management and patient financial engagement. The platform integrates with existing EHR and practice management systems to reduce manual billing work, lower collection costs, and accelerate cash flow for medical groups, health systems, and healthcare payers.
6 investors
Compass Therapeutics develops antibody-based therapies targeting the tumor microenvironment to treat cancer. Its product candidates aim to support an effective anti-tumor immune response.
6 investors
Conceivable builds AURA, a robotic automation platform that automates manual IVF laboratory procedures using physical AI, aiming to increase accessibility and affordability of in-vitro fertilization treatments.
6 investors
Conception develops stem cell technology to create functional reproductive cells in the laboratory, enabling in-vitro gametogenesis as a solution for individuals facing biological and medical fertility barriers.
6 investors
CopilotIQ provides AI-driven remote care management for older Americans with chronic conditions like diabetes and hypertension, combining high-frequency nurse care, connected devices, and a software platform (remoteIQ). The company merged with Biofourmis to create an end-to-end in-home care platform.
6 investors
Cordance Medical is developing NeuroAccess, a non-invasive medical device that uses low-frequency focused ultrasound and microbubbles to reversibly open the blood-brain barrier at targeted sites, enabling drug delivery and blood-based biomarker measurement. It targets brain diseases including brain cancers, Alzheimer's, Parkinson's, and epilepsy, and its device received the FDA's Breakthrough Device Designation.
6 investors
Correlia Bio develops the PIXI platform, a benchtop automated immunoassay system that uses proprietary microfluidic gel technology to quantify proteins from samples as small as 1 uL. Aimed at pharmaceutical and proteomics researchers, it offers a faster alternative to traditional ELISA for protein measurement in laboratory workflows.
6 investors
Crescendo Biologics develops T cell enhancing therapeutics for immuno-oncology, based on its Humabody platform, with clinical candidates including the bispecific CB307 and immune cell engager CB699. Its pipeline targets cancers such as metastatic castration-resistant prostate cancer, and it partners with companies like Zai Lab on additional Humabody-derived treatments.
6 investors
Culture Biosciences provides software and bioreactor hardware solutions for bioprocess development, enabling researchers to design, monitor, and analyze experiments remotely with cloud-native analytics and AI/ML insights.
6 investors